Erik L. Kimble

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

Jordan Gauthier, Evandro D. Bezerra, Alexandre V. Hirayama et al. · Blood · 2020 · 212 citations · Full text

Life Sciences, Hematology, Immunology +13

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Nicolas Gazeau, Emily C. Liang, Qian Wu et al. · Transplantation and Cellular Therapy · 2023 · 135 citations · Full text

Life Sciences, Immunology, Neurology +12

Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution

Juan Pablo Alderuccio, Wei Zhao, Amrita Desai et al. · Journal of Clinical Oncology · 2018 · 79 citations

Medicine, Oncology, Pathology +10

Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients

José F. Camargo, Erik L. Kimble, Rossana Rosa et al. · Biology of Blood and Marrow Transplantation · 2017 · 71 citations · Full text

Medicine, Hematology, Infectious Diseases +14

Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation

José F. Camargo, Eric Wieder, Erik L. Kimble et al. · Blood · 2018 · 55 citations · Full text

Life Sciences, Hematology, Immunology +15